acquired
Stage
About
Decipherbio develops genomic tests that assess the risk of metastatic progression in prostate cancer patients to help guide personalized treatment decisions.
Explore Decipherbio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.